Evidence map›Paper›PMID 34831250›Full record

ArticleCells2021

Acid Sphingomyelinase Controls Early Phases of Skeletal Muscle Regeneration by Shaping the Macrophage Phenotype.

Paulina Roux-Biejat, Marco Coazzoli, Pasquale Marrazzo, Silvia Zecchini, Ilaria Di Renzo, Cecilia Prata, Alessandra Napoli, Claudia Moscheni, Matteo Giovarelli, Maria Cristina Barbalace and 8 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Stem/progenitor cell-based therapy for Duchenne muscular dystrophy.Frontiers in cell and developmental biology · 2025
    Review
  4. Accelerated Sarcopenia Phenotype in the DJ-1/Antioxidants (Basel, Switzerland) · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Paulina Roux-BiejatDepartment of Biomedical and Clinical Sciences "Luigi Sacco" (DIBIC), Università degli Studi di Milano, 20157 Milano, Italy.ORCID 0000-0002-9677-9084
Marco CoazzoliDepartment of Biomedical and Clinical Sciences "Luigi Sacco" (DIBIC), Università degli Studi di Milano, 20157 Milano, Italy.
Pasquale MarrazzoDepartment for Life Quality Studies, Alma Mater Studiorum-University of Bologna, 47921 Rimini, Italy.ORCID 0000-0001-6644-5828
Silvia ZecchiniDepartment of Biomedical and Clinical Sciences "Luigi Sacco" (DIBIC), Università degli Studi di Milano, 20157 Milano, Italy.ORCID 0000-0001-6416-327X
Ilaria Di RenzoDepartment of Biomedical and Clinical Sciences "Luigi Sacco" (DIBIC), Università degli Studi di Milano, 20157 Milano, Italy.
Cecilia PrataDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, 40126 Bologna, Italy.ORCID 0000-0003-2766-9006
Alessandra NapoliDepartment of Biomedical and Clinical Sciences "Luigi Sacco" (DIBIC), Università degli Studi di Milano, 20157 Milano, Italy.ORCID 0000-0001-9691-4103
Claudia MoscheniDepartment of Biomedical and Clinical Sciences "Luigi Sacco" (DIBIC), Università degli Studi di Milano, 20157 Milano, Italy.ORCID 0000-0001-6614-665X
Matteo GiovarelliDepartment of Biomedical and Clinical Sciences "Luigi Sacco" (DIBIC), Università degli Studi di Milano, 20157 Milano, Italy.
Maria Cristina BarbalaceDepartment for Life Quality Studies, Alma Mater Studiorum-University of Bologna, 47921 Rimini, Italy.ORCID 0000-0001-5686-0470
Elisabetta CatalaniDepartment for Innovation in Biological, Agro-Food and Forest Systems (DIBAF), Università degli Studi della Tuscia, 01100 Viterbo, Italy.ORCID 0000-0002-1210-6836
Maria Teresa BassiScientific Institute IRCCS "Eugenio Medea", 23842 Bosisio Parini, Italy.ORCID 0000-0002-8236-1197
Clara De PalmaDepartment of Medical Biotechnology and Translational Medicine (BIOMETRA), Università degli Studi di Milano, 20129 Milano, Italy.ORCID 0000-0003-0365-7414
Davide CerviaDepartment for Innovation in Biological, Agro-Food and Forest Systems (DIBAF), Università degli Studi della Tuscia, 01100 Viterbo, Italy.ORCID 0000-0002-2727-9449
Marco MalagutiDepartment for Life Quality Studies, Alma Mater Studiorum-University of Bologna, 47921 Rimini, Italy.ORCID 0000-0003-0349-7772
Silvana HreliaDepartment for Life Quality Studies, Alma Mater Studiorum-University of Bologna, 47921 Rimini, Italy.ORCID 0000-0001-7857-4512
Emilio ClementiDepartment of Biomedical and Clinical Sciences "Luigi Sacco" (DIBIC), Università degli Studi di Milano, 20157 Milano, Italy.
Cristiana PerrottaDepartment of Biomedical and Clinical Sciences "Luigi Sacco" (DIBIC), Università degli Studi di Milano, 20157 Milano, Italy.ORCID 0000-0001-6680-4536
University of Milan · ITUniversity of Bologna · ITUniversità degli Studi della Tuscia · ITIRCCS Eugenio Medea · IT

Funding

French Muscular Dystrophy Association 23172Ministero dell'Istruzione, Università e Ricerca PRIN2017 2017FJSM9S
6 · The paper itself

Abstract

Skeletal muscle regeneration is a complex process involving crosstalk between immune cells and myogenic precursor cells, i.e., satellite cells. In this scenario, macrophage recruitment in damaged muscles is a mandatory step for tissue repair since pro-inflammatory M1 macrophages promote the activation of satellite cells, stimulating their proliferation and then, after switching into anti-inflammatory M2 macrophages, they prompt satellite cells' differentiation into myotubes and resolve inflammation. Here, we show that acid sphingomyelinase (ASMase), a key enzyme in sphingolipid metabolism, is activated after skeletal muscle injury induced in vivo by the injection of cardiotoxin. ASMase ablation shortens the early phases of skeletal muscle regeneration without affecting satellite cell behavior. Of interest, ASMase regulates the balance between M1 and M2 macrophages in the injured muscles so that the absence of the enzyme reduces inflammation. The analysis of macrophage populations indicates that these events depend on the altered polarization of M1 macrophages towards an M2 phenotype. Our results unravel a novel role of ASMase in regulating immune response during muscle regeneration/repair and suggest ASMase as a supplemental therapeutic target in conditions of redundant inflammation that impairs muscle recovery.

Indexed as

AnimalsCell DifferentiationCell PolarityCell ProliferationEnzyme ActivationInflammationMacrophagesMiceMice, KnockoutMuscle, SkeletalPhenotypeRegenerationSatellite Cells, Skeletal MuscleSignal TransductionSphingomyelin PhosphodiesteraseASMase, mouseSphingomyelin Phosphodiesteraseacid sphingomyelinaseinflammationmacrophage phenotypemuscle regeneration

Identifiers

PMID34831250
PMCPMC8616363
OpenAlexW3211714308

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.